Deroy & Devereaux Private Investment Counsel’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36M Sell
92,427
-1,380
-1% -$583K 1.5% 21
2026
Q1
$44.4M Sell
93,807
-17,467
-16% -$8.79M 2.13% 6
2025
Q4
$52M Sell
111,274
-5,872
-5% -$2.73M 2.53% 3
2025
Q3
$49.9M Sell
117,146
-833
-0.7% -$323K 2.49% 2
2025
Q2
$45.2M Sell
117,979
-2,139
-2% -$771K 2.44% 3
2025
Q1
$41.5M Sell
120,118
-694
-0.6% -$223K 2.41% 5
2024
Q4
$36.3M Buy
120,812
+1,931
+2% +$675K 2.08% 11
2024
Q3
$48.3M Buy
118,881
+395
+0.3% +$145K 2.75% 1
2024
Q2
$38.1M Sell
118,486
-661
-0.6% -$215K 2.35% 3
2024
Q1
$39.7M Sell
119,147
-3,300
-3% -$1.01M 2.42% 4
2023
Q4
$33.1M Buy
122,447
+504
+0.4% +$125K 2.21% 3
2023
Q3
$30M Sell
121,943
-1,714
-1% -$469K 2.19% 5
2023
Q2
$37.5M Sell
123,657
-1,533
-1% -$426K 2.6% 2
2023
Q1
$33M Sell
125,190
-1,341
-1% -$341K 2.51% 3
2022
Q4
$30.4M Buy
126,531
+947
+0.8% +$212K 2.33% 5
2022
Q3
$23.1M Sell
125,584
-99
-0.1% -$19.7K 2% 9
2022
Q2
$21.1M Buy
125,683
+3,139
+3% +$674K 1.75% 19
2022
Q1
$30.7M Sell
122,544
-819
-0.7% -$206K 2.23% 3
2021
Q4
$31.7M Sell
123,363
-3,558
-3% -$871K 2.33% 3
2021
Q3
$30.8M Sell
126,921
-42,479
-25% -$10.4M 2.41% 4
2021
Q2
$35M Sell
169,400
-1,466
-0.9% -$299K 2.63% 2
2021
Q1
$32.2M Sell
170,866
-4,965
-3% -$876K 2.54% 3
2020
Q4
$28.9M Sell
175,831
-14,467
-8% -$2.12M 2.57% 2
2020
Q3
$23.7M Buy
190,298
+4,587
+2% +$568K 2.49% 2
2020
Q2
$18M Buy
185,711
+22,379
+14% +$2.33M 1.99% 15
2020
Q1
$14.7M Buy
163,332
+447
+0.3% +$57.9K 1.92% 22
2019
Q4
$24.1M Buy
162,885
+2,463
+2% +$331K 2.11% 12
2019
Q3
$19.3M Sell
160,422
-2,936
-2% -$379K 1.88% 15
2019
Q2
$22.1M Sell
163,358
-1,440
-0.9% -$182K 2.13% 9
2019
Q1
$21.5M Sell
164,798
-3,409
-2% -$458K 2.15% 9
2018
Q4
$20.9M Buy
168,207
+218
+0.1% +$29.3K 2.42% 4
2018
Q3
$23.4M Sell
167,989
-995
-0.6% -$124K 2.34% 5
2018
Q2
$17.3M Buy
168,984
+402
+0.2% +$40.7K 1.77% 19
2018
Q1
$16.4M Sell
168,582
-807
-0.5% -$78.3K 1.74% 23
2017
Q4
$14.9M Buy
169,389
+194
+0.1% +$15.6K 1.57% 30
2017
Q3
$13.5M Buy
169,195
+1,359
+0.8% +$109K 1.51% 37
2017
Q2
$14.6M Buy
167,836
+1,268
+0.8% +$107K 1.68% 26
2017
Q1
$14.8M Sell
166,568
-3,809
-2% -$318K 1.72% 26
2016
Q4
$12.6M Buy
170,377
+46,239
+37% +$3.46M 1.49% 35
2016
Q3
$9.39M Buy
124,138
+46,616
+60% +$3.57M 1.18% 46
2016
Q2
$5.97M Buy
+77,522
New +$6.12M 0.79% 52

Other funds holding HCA

Deroy & Devereaux Private Investment Counsel's HCA Position: Q2 2026 in Review

Deroy & Devereaux Private Investment Counsel reduced its HCA Healthcare (HCA) stake by 1.5% in Q2 2026, selling an estimated $583K and leaving 92,427 shares worth $36M. The position accounts for 1.5% of the portfolio, ranked #21.

Deroy & Devereaux Private Investment Counsel first reported a position in HCA in Q2 2016 and has held it in 41 quarters since. The position peaked at $52M in Q4 2025. 839 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Deroy & Devereaux Private Investment Counsel held 92,427 shares of HCA Healthcare worth $36M as of Q2 2026.
  • Deroy & Devereaux Private Investment Counsel sold 1,380 HCA Healthcare shares in Q2 2026, an estimated $583K.
  • HCA Healthcare made up 1.5% of Deroy & Devereaux Private Investment Counsel's portfolio in Q2 2026, its #21 holding.
  • Deroy & Devereaux Private Investment Counsel first reported a position in HCA Healthcare in Q2 2016 and has held it in 41 quarters since.
  • Deroy & Devereaux Private Investment Counsel's HCA Healthcare position peaked at $52M in Q4 2025.
  • 839 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Deroy & Devereaux Private Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.